Mok V

References (3)

Title : The patient pathway for mild cognitive impairment due to Alzheimer's disease in Asia: Current practices, barriers, and expert recommendations for optimization - Choi_2025_J.Prev.Alzheimers.Dis__100215
Author(s) : Choi SH , Kim S , Ong PA , Chin AV , Dominguez J , Chen CL , Senanarong V , Hu CJ , Tripathi M , Mok V , Jiang G , Dash A
Ref : J Prev Alzheimers Dis , :100215 , 2025
Abstract :
PubMedSearch : Choi_2025_J.Prev.Alzheimers.Dis__100215
PubMedID: 40483260

Title : Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials - Yu_2020_J.Neurol.Neurosurg.Psychiatry_91_1201
Author(s) : Yu JT , Xu W , Tan CC , Andrieu S , Suckling J , Evangelou E , Pan A , Zhang C , Jia J , Feng L , Kua EH , Wang YJ , Wang HF , Tan MS , Li JQ , Hou XH , Wan Y , Tan L , Mok V , Dong Q , Touchon J , Gauthier S , Aisen PS , Vellas B
Ref : Journal of Neurology Neurosurg Psychiatry , 91 :1201 , 2020
Abstract :
PubMedSearch : Yu_2020_J.Neurol.Neurosurg.Psychiatry_91_1201
PubMedID: 32690803

Title : Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials - Dou_2018_Alzheimers.Res.Ther_10_126
Author(s) : Dou KX , Tan MS , Tan CC , Cao XP , Hou XH , Guo QH , Tan L , Mok V , Yu JT
Ref : Alzheimers Res Ther , 10 :126 , 2018
Abstract :
PubMedSearch : Dou_2018_Alzheimers.Res.Ther_10_126
PubMedID: 30591071